Identification of vaccine-altered circulating B cell phenotypes using mass cytometry and a two-step clustering analysis

Journal of Immunology

Volumn 196, Issue 11, 2016, Pages 4814-4831

  Pejoski, David ^a,b   Tchitchek, Nicolas ^a,b   Pozo, Andre Rodriguez ^a,b   Elhmouzi Younes, Jamila ^a,b   Yousfi Bogniaho, Rahima ^c   Rogez Kreuz, Christine ^c   Clayette, Pascal ^c   Dereuddre Bosquet, Nathalie ^a,b   Lévy, Yves ^b   Cosma, Antonio ^a,b   Le Grand, Roger ^a,b   Beignon, Anne Sophie ^a,b  

^a INSERM U1184   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c ImmunoPharmacology and Biosafety Laboratory   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD20 ANTIGEN; CD27 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; VACCINE;

ALGORITHM; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL ASSAY; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOMETRY; DOUBLE HIERARCHICAL CLUSTERING; HUMORAL IMMUNITY; IMMUNE RESPONSE; MACACA FASCICULARIS; MASS CYTOMETRY; MEMORY CELL; MULTIVARIATE ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; SPANNING TREE PROGRESSION ANALYSIS OF DENSITY NORMALIZED EVENT CLUSTER; STEADY STATE; ANIMAL; B LYMPHOCYTE; FLOW CYTOMETRY; IMMUNOLOGY; MALE;

ANIMALS; B-LYMPHOCYTES; CLUSTER ANALYSIS; FLOW CYTOMETRY; MACACA FASCICULARIS; MALE; PHENOTYPE; VACCINES;

EID: 84975114095     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502005     Document Type: Article

References (94)

1. Amanna, I. J., M. K. Slifka, and S. Crotty. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211: 320-337.
2. Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9: 1131-1137.
3. Chaudhri, G., V. Panchanathan, H. Bluethmann, and G. Karupiah. 2006. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J. Virol. 80: 6339-6344.
4. Panchanathan, V., G. Chaudhri, and G. Karupiah. 2006. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J. Virol. 80: 6333-6338.
5. Panchanathan, V., G. Chaudhri, and G. Karupiah. 2008. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86: 80-86.
6. Kempe, C. H., C. Bowles, G. Meiklejohn, T. O. Berge, L. St Vincent, B. V. Babu, S. Govindarajan, N. R. Ratnakannan, A. W. Downie, and V. R. Murthy. 1961. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull. World Health Organ. 25: 41-48.
7. Moss, B. 2011. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239: 8-26.
8. Hopkins, R. J., and J. M. Lane. 2004. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin. Infect. Dis. 39: 819-826.
9. Plotkin, S. A. 2010. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17: 1055-1065.
10. Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171: 4969-4973.
11. Jacobs, B. L., J. O. Langland, K. V. Kibler, K. L. Denzler, S. D. White, S. A. Holechek, S. Wong, T. Huynh, and C. R. Baskin. 2009. Vaccinia virus vaccines: past, present and future. Antiviral Res. 84: 1-13.
12. Earl, P. L., J. L. Americo, L. S. Wyatt, L. A. Eller, J. C. Whitbeck, G. H. Cohen, R. J. Eisenberg, C. J. Hartmann, D. L. Jackson, D. A. Kulesh, et al. 2004. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428: 182-185.
13. Stittelaar, K. J., G. van Amerongen, I. Kondova, T. Kuiken, R. F. van Lavieren, F. H. M. Pistoor, H. G. M. Niesters, G. van Doornum, B. A. van der Zeijst, L. Mateo, et al. 2005. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J. Virol. 79: 7845-7851.
14. Stittelaar, K. J., T. Kuiken, R. L. de Swart, G. van Amerongen, H. W. Vos, H. G. M. Niesters, P. van Schalkwijk, T. van der Kwast, L. S. Wyatt, B. Moss, and A. D. M. E. Osterhaus. 2001. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19: 3700-3709.
15. Brookes, R. H., P. C. Hill, P. K. Owiafe, H. B. Ibanga, D. J. Jeffries, S. A. Donkor, H. A. Fletcher, A. S. Hammond, C. Lienhardt, R. A. Adegbola, et al. 2008. Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa. [Published erratum appears in 2011 PLoS One. 6(2).] PLoS One 3: e2921.
16. Pathan, A. A., A. M. Minassian, C. R. Sander, R. Rowland, D. W. Porter, I. D. Poulton, A. V. S. Hill, H. A. Fletcher, and H. McShane. 2012. Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults. Vaccine 30: 5616-5624.
17. Blanchard, T. J., A. Alcaḿ, P. Andrea, and G. L. Smith. 1998. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J. Gen. Virol. 79: 1159-1167.
18. Swadling, L., S. Capone, R. D. Antrobus, A. Brown, R. Richardson, E. W. Newell, J. Halliday, C. Kelly, D. Bowen, J. Fergusson, et al. 2014. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci. Transl. Med. 6: 261ra153.
19. García-Arriaza, J., P. Arnáez, C. E. Gómez, C. O . S. Sorzano, and M. Esteban. 2013. Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways. PLoS One 8: e66894.
20. Harrop, R., N. Connolly, I. Redchenko, J. Valle, M. Saunders, M. G. Ryan, K. A. Myers, N. Drury, S. M. Kingsman, R. E. Hawkins, and M. W. Carroll. 2006. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial. Clin. Cancer Res. 12: 3416-3424.
21. Griffiths, K. L., A. A. Pathan, A. M. Minassian, C. R. Sander, N. E. R. Beveridge, A. V. S. Hill, H. A. Fletcher, and H. McShane. 2011. Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. PLoS One 6: e23463.
22. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
23. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
24. Yoshida, T., H. Mei, T. Dörner, F. Hiepe, A. Radbruch, S. Fillatreau, and B. F. Hoyer. 2010. Memory B and memory plasma cells. Immunol. Rev. 237: 117-139.
25. + memory B cells. Clin. Immunol. 140: 223-228.
26. Demberg, T., E. Brocca-Cofano, P. Xiao, D. Venzon, D. Vargas-Inchaustegui, E. M. Lee, I. Kalisz, V. S. Kalyanaraman, J. Dipasquale, K. McKinnon, and M. Robert-Guroff. 2012. Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J. Virol. 86: 12591-12604.
27. Nair, N., E. W. Newell, C. Vollmers, S. R. Quake, J. M. Morton, M. M. Davis, X. S. He, and H. B. Greenberg. 2016. High-dimensional immune profiling of total and rotavirus VP6-specific intestinal and circulating B cells by mass cytometry. Mucosal Immunol. 9: 68-82.
28. Kaminski, D. A., C. Wei, Y. Qian, A. F. Rosenberg, and I. Sanz. 2012. Advances in human B cell phenotypic profiling. Front. Immunol. 3: 302.
29. Nolan, J. P., and D. Condello. 2013. Spectral flow cytometry. Curr. Protoc. Cytom. Chapter 1: Unit 1.27.
30. Bendall, S. C., G. P. Nolan, M. Roederer, and P. K. Chattopadhyay. 2012. A deep profiler's guide to cytometry. Trends Immunol. 33: 323-332.
31. + T cell phenotypes. [Published erratum appears in 2013 Immunity 38: 198-199.] Immunity 36: 142-152.
32. Mason, G. M., K. Lowe, R. Melchiotti, R. Ellis, E. de Rinaldis, M. Peakman, S. Heck, G. Lombardi, and T. I. M. Tree. 2015. Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry. J. Immunol. 195: 2030-2037.
33. Wong, M. T., J. Chen, S. Narayanan, W. Lin, R. Anicete, H. T. K. Kiaang, M. A. C. De Lafaille, M. Poidinger, and E. W. Newell. 2015. Mapping the Diversity of Follicular Helper T Cells in Human Blood and Tonsils Using High-Dimensional Mass Cytometry Analysis. Cell Reports 11: 1822-1833.
34. Bendall, S. C., K. L. Davis, A. D. Amir, M. D. Tadmor, E. F. Simonds, T. J. Chen, D. K. Shenfeld, G. P. Nolan, and D. Pe'er. 2014. Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell 157: 714-725.
35. Hansmann, L., L. Blum, C. H. Ju, M. Liedtke,W. H. Robinson, and M. M. Davis. 2015. Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma. Cancer Immunol. Res. 3: 650-660.
36. Polikowsky, H. G., C. E. Wogsland, K. E. Diggins, K. Huse, and J. M. Irish. 2015. Cutting Edge: Redox Signaling Hypersensitivity Distinguishes Human Germinal Center B Cells. J. Immunol. 195: 1364-1367.
37. O'Gorman, W. E., H. Huang, Y.-L. Wei, K. L. Davis, M. D. Leipold, S. C. Bendall, B. A. Kidd, C. L. Dekker, H. T. Maecker, Y.-H. Chien, and M. M. Davis. 2014. The Split Virus Influenza Vaccine rapidly activates immune cells through Fcg receptors. Vaccine 32: 5989-5997.
38. Suryani, S., D. A. Fulcher, B. Santner-Nanan, R. Nanan, M. Wong, P. J. Shaw, J. Gibson, A. Williams, and S. G. Tangye. 2010. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 115: 519-529.
39. Nakaya, H. I., J. Wrammert, E. K. Lee, L. Racioppi, S. Marie-Kunze, W. N. Haining, A. R. Means, S. P. Kasturi, N. Khan, G. M. Li, et al. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12: 786-795.
40. Querec, T. D., R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10: 116-125.
41. Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake, III, E. Castro, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.
42. Li, S., N. Rouphael, S. Duraisingham, S. Romero-Steiner, S. Presnell, C. Davis, D. S. Schmidt, S. E. Johnson, A. Milton, G. Rajam, et al. 2014. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15: 195-204.
43. He, Y., Z. Xiang, and H. L. T. Mobley. 2010. Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J. Biomed. Biotechnol. 2010: 297505.
44. Poland, G. A., R. B. Kennedy, B. A. McKinney, I. G. Ovsyannikova, N. D. Lambert, R. M. Jacobson, and A. L. Oberg. 2013. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin. Immunol. 25: 89-103.
45. Gujer, C., C. Sundling, R. A. Seder, G. B. Karlsson Hedestam, and K. Loré. 2011. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology 134: 257-269.
46. Perez-Andres, M., B. Paiva, W. G. Nieto, A. Caraux, A. Schmitz, J. Almeida, R. F. Vogt, G. E. Marti, A. C. Rawstron, M. C. Van Zelm, et al. 2010. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin. Cytom. 78(Suppl. 1): S47-S60.
47. Mamani-Matsuda, M., A. Cosma, S. Weller, A. Faili, C. Staib, L. Garçon, O. Hermine, O. Beyne-Rauzy, C. Fieschi, J. O. Pers, et al. 2008. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 111: 4653-4659.
48. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69: 1895-1902.
49. Brandler, S., A. Lepelley, M. Desdouits, F. Guivel-Benhassine, P.-E. Ceccaldi, Y. Lévy, O. Schwartz, and A. Moris. 2010. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect. J. Virol. 84: 5314-5328.
50. Tricot, S., M. Meyrand, C. Sammicheli, J. Elhmouzi-Younes, A. Corneau, S. Bertholet, M. Malissen, R. Le Grand, S. Nuti, H. Luche, et al. 2015. Evaluating the efficiency of isotope transmission for improved panel design and a comparison of the detection sensitivities of mass cytometer instruments. Cytom. Part A 87: 357-358.
51. Finck, R., E. F. Simonds, A. Jager, S. Krishnaswamy, K. Sachs, W. Fantl, D. Pe'er, G. P. Nolan, and S. C. Bendall. 2013. Normalization of mass cytometry data with bead standards. Cytom. Part A 83: 483-494.
52. Linderman, M. D., Z. Bjornson, E. F. Simonds, P. Qiu, R. V. Bruggner, K. Sheode, T. H. Meng, S. K. Plevritis, and G. P. Nolan. 2012. CytoSPADE: high-performance analysis and visualization of high-dimensional cytometry data. Bioinformatics 28: 2400-2401.
53. Kruskal, J. B., and M. Wish. 1978. Multidimensional Scaling. SAGE Publications, Beverly Hills, London.
54. Shekhar, K., P. Brodin, M. M. Davis, and A. K. Chakraborty. 2014. Automatic classification of cellular expression by nonlinear stochastic embedding (ACCENSE). Proc. Natl. Acad. Sci. USA 111: 202-207.
55. Neumann, B., A. Klippert, K. Raue, S. Sopper, and C. Stahl-Hennig. 2015. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J. Leukoc. Biol. 97: 19-30.
56. Silveira, E. L. V., S. P. Kasturi, Y. Kovalenkov, A. U. Rasheed, P. Yeiser, Z. S. Jinnah, T. H. Legere, B. Pulendran, F. Villinger, and J. Wrammert. 2015. Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies. J. Immunol. Methods 416: 69-83.
57. Qiu, P., E. F. Simonds, S. C. Bendall, K. D. Gibbs, Jr., R. V. Bruggner, M. D. Linderman, K. Sachs, G. P. Nolan, and S. K. Plevritis. 2011. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29: 886-891.
58. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868.
59. Bendall, S. C., E. F. Simonds, P. Qiu, E. D. Amir, P. O. Krutzik, R. Finck, R. V. Bruggner, R. Melamed, A. Trejo, O. I. Ornatsky, et al. 2011. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332: 687-696.
60. Behbehani, G. K., S. C. Bendall, M. R. Clutter, W. J. Fantl, and G. P. Nolan. 2012. Single-cell mass cytometry adapted to measurements of the cell cycle. Cytom. Part A 81: 552-566.
61. Bodenmiller, B., E. R. Zunder, R. Finck, T. J. Chen, E. S. Savig, R. V. Bruggner, E. F. Simonds, S. C. Bendall, K. Sachs, P. O. Krutzik, and G. P. Nolan. 2012. Multiplexed mass cytometry profiling of cellular states perturbed by smallmolecule regulators. Nat. Biotechnol. 30: 858-867.
62. Horowitz, A., D. M. Strauss-Albee, M. Leipold, J. Kubo, N. Nemat-Gorgani, O. C. Dogan, C. L. Dekker, S. Mackey, H. Maecker, G. E. Swan, et al. 2013. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5: 208ra145.
63. Yao, Y., R. Liu, M. S. Shin, M. Trentalange, H. Allore, A. Nassar, I. Kang, J. S. Pober, and R. R. Montgomery. 2014. CyTOF supports efficient detection of immune cell subsets from small samples. J. Immunol. Methods 415: 1-5.
64. Sen, N., G. Mukherjee, A. Sen, S. C. Bendall, P. Sung, G. P. Nolan, and A. M. Arvin. 2014. Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Reports 8: 633-645.
65. Tangye, S. G., and D. M. Tarlinton. 2009. Memory B cells: effectors of longlived immune responses. Eur. J. Immunol. 39: 2065-2075.
66. Vugmeyster, Y., K. Howell, A. Bakshi, C. Flores, O. Hwang, and K. McKeever. 2004. B-cell subsets in blood and lymphoid organs in Macaca fascicularis. Cytometry A 61: 69-75.
67. Moir, S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, S. Kottilil, J. Arthos, M. A. Proschan, et al. 2008. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIVinfected viremic individuals. J. Exp. Med. 205: 1797-1805.
68. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
69. Kardava, L., S. Moir, N. Shah, W. Wang, R. Wilson, C. M. Buckner, B. H. Santich, L. J. Y. Kim, E. E. Spurlin, A. K. Nelson, et al. 2014. Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. J. Clin. Invest. 124: 3252-3262.
70. Sundling, C., P. Martinez, M. Soldemo, M. Spangberg, K. L. Bengtsson, L. Stertman, M. N. E. Forsell, and G. B. Karlsson Hedestam. 2013. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting. J. Infect. Dis. 207: 426-431.
71. Chester, C., and H. T. Maecker. 2015. Algorithmic Tools for Mining High-Dimensional Cytometry Data. J. Immunol. 195: 773-779.
72. Mair, F., F. J. Hartmann, D. Mrdjen, V. Tosevski, C. Krieg, and B. Becher. 2016. The end of gating An introduction to automated analysis of high dimensional cytometry data. Eur. J. Immunol. 46: 34-43.
73. González-García, I., E. Ocaña, G. Jiménez-Gómez, A. Campos-Caro, and J. A. Brieva. 2006. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDi-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J. Immunol. 176: 4042-4050.
74. Odendahl, M., H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen, G. Muehlinghaus, C. Berek, F. Hiepe, R. Manz, A. Radbruch, and T. Dörner. 2005. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105: 1614-1621.
75. Arce, S., E. Luger, G. Muehlinghaus, G. Cassese, A. Hauser, A. Horst, K. Lehnert, M. Odendahl, D. Hönemann, K.-D. Heller, et al. 2004. CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations. J. Leukoc. Biol. 75: 1022-1028.
76. Moody, M. A., and B. F. Haynes. 2008. Antigen-specific B cell detection reagents: use and quality control. Cytometry A 73: 1086-1092.
77. Taylor, J. J., K. A. Pape, and M. K. Jenkins. 2012. A germinal centerindependent pathway generates unswitched memory B cells early in the primary response. J. Exp. Med. 209: 597-606.
78. Scherer, E. M., R. A. Smith, C. A. Simonich, N. Niyonzima, J. J. Carter, and D. A. Galloway. 2014. Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity. [Published erratum appears in 2014 PLoS Pathog. 10: e1004612.] PLoS Pathog. 10: e1004461.
79. Franz, B., K. F. May, Jr., G. Dranoff, and K. Wucherpfennig. 2011. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 118: 348-357.
80. Kunkel, E. J., and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829.
81. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329.
82. + B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J. Immunol. 177: 3728-3736.
83. Illingworth, J., N. S. Butler, S. Roetynck, J. Mwacharo, S. K. Pierce, P. Bejon, P. D. Crompton, K. Marsh, and F. M. Ndungu. 2013. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 190: 1038-1047.
84. Muellenbeck, M. F., B. Ueberheide, B. Amulic, A. Epp, D. Fenyo, C. E. Busse, M. Esen, M. Theisen, B. Mordmuller, and H. Wardemann. 2013. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 210: 389-399.
85. Hu, Z., Z. Luo, Z. Wan, H. Wu, W. Li, T. Zhang, and W. Jiang. 2015. HIVassociated memory B cell perturbations. Vaccine 33: 2524-2529.
86. Moir, S., and A. S. Fauci. 2013. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol. Rev. 254: 207-224.
87. Weinberg, A., P. Muresan, K. M. Richardson, T. Fenton, T. Dominguez, A. Bloom, D. H. Watts, M. J. Abzug, S. A. Nachman, and M. J. Levin, P1086 team. 2015. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS One 10: e0122431.
88. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigenspecific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
89. Kuhrt, D., S. Faith, A. Hattemer, A. Leone, D. Sodora, L. Picker, L. Borghesi, and K. S. Cole. 2011. Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation. J. Immunol. Methods 363: 166-176.
90. Bjornson, Z. B., G. P. Nolan, and W. J. Fantl. 2013. Single-cell mass cytometry for analysis of immune system functional states. Curr. Opin. Immunol. 25: 484-494.
91. Sullivan, R. T., C. C. Kim, M. F. Fontana, M. E. Feeney, P. Jagannathan, M. J. Boyle, C. J. Drakeley, I. Ssewanyana, F. Nankya, H. Mayanja-Kizza, et al. 2015. FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure. PLoS Pathog. 11: e1004894.
92. Diggins, K. E., P. B. Ferrell, Jr., and J. M. Irish. 2015. Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data. Methods 82: 55-63.
93. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172.
94. Sancho, D., M. Gómez, and F. Sánchez-Madrid. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26: 136-140.